Arm Holdings plc
ARMArm Holdings plc's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +103.9% in a year while annual EPS moved +13.3% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (20 weeks in). Underneath, the last four quarters read improving — profit +47.6% year on year, and 151% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Arm Holdings plc trades at $281, in a confirmed uptrend and 20 weeks into that stage. That is +47.1% against its own 200-day average. It sits at 52% of a 52-week range of $105 to $439. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 21 straight weeks.
Today the stock is in a confirmed uptrend — week 20 of stage 2. At $281 it trades +47.1% versus its 200-day average and sits at 52% of its 52-week range ($105–$439).
Against the market, two honest reads. Cumulative: over the last 2.9 years the stock moved +362% while the S&P 500 moved +74% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 21 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Arm Holdings plc trades at 286.4× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 286.4× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved +13.3% against a +103.9% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +66.5%/yr price move, ~+29.1%/yr came from earnings growth and ~+37.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Arm Holdings plc reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +276.5% at its peak to +13.9% but is still expanding, ROCE holding at 10.1%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +22.7% | +22.4% | — | — |
| Profit | +13.9% | +20.1% | — | — |
| EPS | +13.3% | +18.6% | — | — |
| Stock price | +103.9% | +66.5% | — | — |
4-Factor Sector Score
48.9/100 — rank 14 of 27 in Semiconductors · 56% evidence confidence
Arm Holdings plc scores 48.9 out of 100 against the 27 companies it is compared with in Semiconductors, ranking 14. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 13.7 + 9.1 + 8.7 + 17.4 = 48.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Arm Holdings plc reported $1.5 B of revenue in the Mar 26 quarter, +20.2% year on year. That is the 11th straight quarter of year-on-year growth. Over 4 years it has compounded at 16.2% a year. The last full year, FY26, came in at $4.9 B. The last four reported quarters add to $4.9 B.
FY26 revenue came in at $4.9 B (+22.7% on the year), capping 4 years at 16.2% compound. The latest quarter (Mar 26) printed $1.5 B, +20.2% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +23.5% growth against the decade's 16.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +23.0% over the last 4 quarters against +23.2%/yr over the last 8 — stabilising; TTM profit +13.9% vs +73.2%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Arm Holdings plc's operating margin is 29.5% in the Mar 26 quarter, −3.6 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 3.4% to 25.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 29.5%, −3.6 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 3.4%–25.0%.
🚨 Why the margin moved: operating margin went −3.6 pp year on year while gross margin went +0.4 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Arm Holdings plc earned $0.3 B of net profit in the Mar 26 quarter, +47.6% year on year. Full-year FY26 profit was $0.9 B. The 4-year compound rate is 7.3%. That is 20.8% of the quarter's revenue. The same quarter a year earlier earned $0.2 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.3 B, +47.6% year on year. On the full year, FY26 printed $0.9 B (+13.9%), and the 4-year compound rate is 7.3%.
Why profit moved: revenue contributed +20.2% and the margin −3.6 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +28.2% vs revenue +23.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 151% of Arm Holdings plc's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $1.5 B of operating cash against $0.9 B of profit. After $0.6 B of capital spending, $1.0 B was left as free cash.
FY26: operating cash of $1.5 B against reported profit of $0.9 B, leaving free cash of $1.0 B after $0.6 B of capital spending. Across the last 3 fiscal years the conversion rate is 151% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Arm Holdings plc does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 6.8% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Arm Holdings plc earns a ROE of 11% in FY26. That is up from a trough of 6% in FY24. Return on invested capital clears the cost of that capital by −11.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 18.3% net margin on 0.46× asset turns.
FY26 ROE is 11%, recovered from a FY24 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 18.3% net margin × 0.46× asset turns × 1.29× balance-sheet leverage ≈ 10.9% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 14.2% − 25.9% = a −11.7 pp spread. The 25.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
Arm Holdings plc pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Arm Holdings plc does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Arm Holdings plc carries total debt of $0.5 B against shareholder equity of $8.6 B as of Jun 26, a debt-to-equity of 0.05 — effectively unlevered. On the annual view that ratio went from 0.07 in FY22 to 0.05 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Jun 26: total debt of $0.5 B against shareholder equity of $8.6 B — a debt-to-equity of 0.05. On the annual view, debt-to-equity went from 0.07 (FY22) to 0.05 (FY26). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Arm Holdings plc, so this section names the gap rather than filling it. At typical trading volumes those positions would take about 1.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Arm Holdings plc: the Z-score reads 43.93. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 43.93 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 43.93.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Micron Technology, Inc.MU | 74.0/100Favorable setup71% evidence | LEADER | 28.4/35 Revenue 100% · PAT 100% · OPM change 57.1 pp 83% evidence | 19.5/25 ROCE 36.4% · OPM 80.4% 76% evidence | 11.5/20 P/E 20.9× · PEG — 15% evidence | 14.6/20 RS sector 49.3% · RS bench 78.5% · 1Y 650.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28.4 + 19.5 + 11.5 + 14.6 = 74 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2NVIDIA CorporationNVDA | 72.3/100Favorable setup81% evidence | ASLEEP | 28.0/35 Revenue 70.7% · PAT 100% · OPM change 16.5 pp 83% evidence | 21.3/25 ROCE 34.1% · OPM 65.6% 76% evidence | 15.1/20 P/E 31.9× · PEG 0.79 65% evidence | 7.9/20 RS sector -27.2% · RS bench 0.2% · 1Y 16%4 of 12 weeks ahead 100% evidence |
| Exact sum: 28 + 21.3 + 15.1 + 7.9 = 72.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Credo Technology Group Holding LtdCRDO | 64.9/100Mixed-positive evidence71% evidence | LEADER | 26.2/35 Revenue 100% · PAT 100% · OPM change 15.8 pp 83% evidence | 14.1/25 ROCE 11.1% · OPM 35.7% 76% evidence | 9.8/20 P/E 73.5× · PEG — 15% evidence | 14.8/20 RS sector -0.5% · RS bench 32.5% · 1Y 97.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.2 + 14.1 + 9.8 + 14.8 = 64.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Silicon Motion Technology CorporationSIMO | 63.5/100Thin evidence · provisional56% evidence | FADING | 22.5/35 Revenue — · PAT — · OPM change 9.4 pp 39% evidence | 15.6/25 ROCE 10.3% · OPM 15.3% 76% evidence | 10.7/20 P/E 39.1× · PEG — 15% evidence | 14.7/20 RS sector 29.7% · RS bench 60.2% · 1Y 251.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 15.6 + 10.7 + 14.7 = 63.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Astera Labs, Inc.ALAB | 62.2/100Thin evidence · provisional56% evidence | LEADER | 22.8/35 Revenue 100% · PAT 100% · OPM change 13 pp 53% evidence | 11.3/25 ROCE 4.8% · OPM 20.1% 57% evidence | 9.7/20 P/E 74.1× · PEG — 15% evidence | 18.4/20 RS sector 19.9% · RS bench 56.4% · 1Y 101.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 11.3 + 9.7 + 18.4 = 62.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Advanced Micro Devices, Inc.AMD | 58.4/100Thin evidence · provisional56% evidence | LEADER | 20.0/35 Revenue 35% · PAT 100% · OPM change 3.6 pp 53% evidence | 10.9/25 ROCE 2.2% · OPM 14.4% 57% evidence | 10.0/20 P/E 66× · PEG — 15% evidence | 17.5/20 RS sector 28.7% · RS bench 62.4% · 1Y 200.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 10.9 + 10 + 17.5 = 58.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Texas Instruments IncorporatedTXN | 57.4/100Thin evidence · provisional56% evidence | FADING | 19.9/35 Revenue — · PAT — · OPM change 5 pp 39% evidence | 15.6/25 ROCE 7.1% · OPM 37.5% 76% evidence | 10.5/20 P/E 45.4× · PEG — 15% evidence | 11.4/20 RS sector -12.4% · RS bench 16.3% · 1Y 51.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.9 + 15.6 + 10.5 + 11.4 = 57.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Lattice Semiconductor CorporationLSCC | 55.2/100Thin evidence · provisional56% evidence | FADING | 20.7/35 Revenue — · PAT — · OPM change 11.5 pp 39% evidence | 11.6/25 ROCE 3.4% · OPM 15.3% 76% evidence | 8.6/20 P/E 678.7× · PEG — 15% evidence | 14.3/20 RS sector 0.2% · RS bench 30.6% · 1Y 124.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 11.6 + 8.6 + 14.3 = 55.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Broadcom Inc.AVGO | 54.9/100Mixed-positive evidence81% evidence | ASLEEP | 24.6/35 Revenue 32.3% · PAT 100% · OPM change 9.8 pp 83% evidence | 15.3/25 ROCE 7.1% · OPM 48.6% 76% evidence | 5.7/20 P/E 70.2× · PEG 5.05 65% evidence | 9.3/20 RS sector -23.6% · RS bench 4.9% · 1Y 37.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 15.3 + 5.7 + 9.3 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Analog Devices, Inc.ADI | 54.9/100Mixed-positive evidence81% evidence | ASLEEP | 20.6/35 Revenue 29.8% · PAT 81% · OPM change 12.4 pp 83% evidence | 13.9/25 ROCE 3.1% · OPM 38.1% 76% evidence | 11.8/20 P/E 58.5× · PEG 1.32 65% evidence | 8.6/20 RS sector -18.5% · RS bench 8.7% · 1Y 69.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 13.9 + 11.8 + 8.6 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Monolithic Power Systems, Inc.MPWR | 51.4/100Thin evidence · provisional56% evidence | ASLEEP | 20.1/35 Revenue — · PAT — · OPM change 3.5 pp 39% evidence | 15.8/25 ROCE 7.8% · OPM 30% 76% evidence | 9.4/20 P/E 84.6× · PEG — 15% evidence | 6.1/20 RS sector -21.1% · RS bench 4.9% · 1Y 66%6 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 15.8 + 9.4 + 6.1 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Marvell Technology, Inc.MRVL | 50.7/100Mixed-positive evidence64% evidence | LEADER | 14.5/35 Revenue 34.1% · PAT — · OPM change -0.3 pp 62% evidence | 7.2/25 ROCE 1.6% · OPM 14% 76% evidence | 10.3/20 P/E 56.5× · PEG — 15% evidence | 18.7/20 RS sector 27.7% · RS bench 58.7% · 1Y 182.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 7.2 + 10.3 + 18.7 = 50.7 · Decision use: Price leads the evidence: RS versus the benchmark is 58.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13NXP Semiconductors N.V.NXPI | 49.6/100Thin evidence · provisional56% evidence | ASLEEP | 20.5/35 Revenue — · PAT — · OPM change 21.8 pp 39% evidence | 15.1/25 ROCE 4.9% · OPM 47.3% 76% evidence | 11.2/20 P/E 23.6× · PEG — 15% evidence | 2.8/20 RS sector -33.7% · RS bench -9.9% · 1Y 14.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 15.1 + 11.2 + 2.8 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Arm Holdings plcthis pageARM | 48.9/100Thin evidence · provisional56% evidence | LEADER | 13.7/35 Revenue — · PAT — · OPM change -3.6 pp 39% evidence | 9.1/25 ROCE 1% · OPM 29.4% 76% evidence | 8.7/20 P/E 365.5× · PEG — 15% evidence | 17.4/20 RS sector 8.7% · RS bench 38.8% · 1Y 102.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 13.7 + 9.1 + 8.7 + 17.4 = 48.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Tower Semiconductor Ltd.TSEM | 47.8/100Mixed-negative evidence66% evidence | TURNING | 16.4/35 Revenue 10.6% · PAT 20.5% · OPM change 6.4 pp 53% evidence | 11.7/25 ROCE 2.1% · OPM 15.6% 57% evidence | 6.1/20 P/E 81.6× · PEG 4.35 65% evidence | 13.6/20 RS sector 16.1% · RS bench 45.1% · 1Y 397%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 11.7 + 6.1 + 13.6 = 47.8 · Decision use: Price leads the evidence: RS versus the benchmark is 45.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Microchip Technology IncorporatedMCHP | 47.2/100Mixed-negative evidence61% evidence | FADING | 18.6/35 Revenue 7.1% · PAT — · OPM change 26.9 pp 40% evidence | 9.9/25 ROCE 1.6% · OPM 16.6% 57% evidence | 13.7/20 P/E 293.7× · PEG 0.78 65% evidence | 5.0/20 RS sector -26.4% · RS bench -0.8% · 1Y 30.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 9.9 + 13.7 + 5 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17ON Semiconductor CorporationON | 43.3/100Thin evidence · provisional53% evidence | FADING | 21.6/35 Revenue — · PAT — · OPM change 36.2 pp 32% evidence | 5.4/25 ROCE -0.5% · OPM -3.5% 76% evidence | 10.6/20 P/E 44.1× · PEG — 15% evidence | 5.7/20 RS sector -19.4% · RS bench 4.5% · 1Y 69.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 5.4 + 10.6 + 5.7 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18STMicroelectronics N.V.STM | 42.7/100Thin evidence · provisional56% evidence | FADING | 17.6/35 Revenue — · PAT — · OPM change 2.2 pp 39% evidence | 6.0/25 ROCE 0.8% · OPM 2.3% 76% evidence | 9.1/20 P/E 139× · PEG — 15% evidence | 10.0/20 RS sector -0.8% · RS bench 25.3% · 1Y 115.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 17.6 + 6 + 9.1 + 10 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19SiTime CorporationSITM | 42.5/100Thin evidence · provisional51% evidence | FADING | 20.2/35 Revenue 65.2% · PAT — · OPM change 35.7 pp 40% evidence | 5.5/25 ROCE -1.2% · OPM -10.9% 57% evidence | 9.3/20 P/E 98.7× · PEG — 15% evidence | 7.5/20 RS sector -2.7% · RS bench 24.4% · 1Y 192.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 5.5 + 9.3 + 7.5 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Qorvo, Inc.QRVO | 41.9/100Thin evidence · provisional56% evidence | TURNING | 16.2/35 Revenue — · PAT — · OPM change 0.7 pp 39% evidence | 7.1/25 ROCE 1.9% · OPM 3.9% 76% evidence | 11.4/20 P/E 21.8× · PEG — 15% evidence | 7.2/20 RS sector -29.9% · RS bench -2.8% · 1Y 7.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 7.1 + 11.4 + 7.2 = 41.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Intel CorporationINTC | 41.6/100Thin evidence · provisional56% evidence | FADING | 15.9/35 Revenue — · PAT — · OPM change -20.7 pp 39% evidence | 4.7/25 ROCE 1.1% · OPM -23.1% 76% evidence | 8.5/20 P/E 3550× · PEG — 15% evidence | 12.5/20 RS sector 23.8% · RS bench 51.4% · 1Y 406%10 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 4.7 + 8.5 + 12.5 = 41.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Rambus Inc.RMBS | 40.0/100Thin evidence · provisional56% evidence | ASLEEP | 14.5/35 Revenue — · PAT — · OPM change -3.6 pp 39% evidence | 14.3/25 ROCE 5% · OPM 34.3% 76% evidence | 10.1/20 P/E 60.9× · PEG — 15% evidence | 1.1/20 RS sector -36.1% · RS bench -13.7% · 1Y 38%7 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 14.3 + 10.1 + 1.1 = 40 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23MACOM Technology Solutions Holdings, Inc.MTSI | 39.4/100Mixed-negative evidence66% evidence | FADING | 17.3/35 Revenue — · PAT — · OPM change 2.8 pp 39% evidence | 11.6/25 ROCE 2.9% · OPM 17.6% 76% evidence | 4.2/20 P/E 103.2× · PEG 5.61 65% evidence | 6.3/20 RS sector -14.7% · RS bench 9.6% · 1Y 126%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 11.6 + 4.2 + 6.3 = 39.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24QUALCOMM IncorporatedQCOM | 38.5/100Thin evidence · provisional56% evidence | ASLEEP | 12.6/35 Revenue — · PAT — · OPM change -6.6 pp 39% evidence | 13.1/25 ROCE 3.5% · OPM 21.8% 76% evidence | 11.3/20 P/E 21.9× · PEG — 15% evidence | 1.5/20 RS sector -36.4% · RS bench -12.8% · 1Y 10.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 13.1 + 11.3 + 1.5 = 38.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25GLOBALFOUNDRIES Inc.GFS | 38.5/100Thin evidence · provisional51% evidence | FADING | 14.9/35 Revenue 0.8% · PAT — · OPM change 1.5 pp 40% evidence | 9.6/25 ROCE 1.3% · OPM 11% 57% evidence | 10.9/20 P/E 32× · PEG — 15% evidence | 3.1/20 RS sector -24.6% · RS bench -2.3% · 1Y 61.1%8 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 9.6 + 10.9 + 3.1 = 38.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Semtech CorporationSMTC | 38.3/100Mixed-negative evidence64% evidence | FADING | 10.7/35 Revenue 14.3% · PAT — · OPM change -5.4 pp 62% evidence | 7.3/25 ROCE 2.2% · OPM 8.9% 76% evidence | 9.0/20 P/E 218.7× · PEG — 15% evidence | 11.3/20 RS sector -1.7% · RS bench 26.7% · 1Y 154%11 of 12 weeks ahead 100% evidence |
| Exact sum: 10.7 + 7.3 + 9 + 11.3 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Skyworks Solutions, Inc.SWKS | 38.0/100Thin evidence · provisional56% evidence | ASLEEP | 13.6/35 Revenue — · PAT — · OPM change -7 pp 39% evidence | 7.5/25 ROCE 0.7% · OPM 4.5% 76% evidence | 10.8/20 P/E 32.4× · PEG — 15% evidence | 6.1/20 RS sector -35.7% · RS bench -9.9% · 1Y -6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 13.6 + 7.5 + 10.8 + 6.1 = 38 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Arm Holdings plc's stock price today?
Arm Holdings plc trades at $281, +103.9% over the past year. The company is valued at $300 B. The stock sits at 52% of its 52-week range of $105–$439, +47.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 20 weeks in. — as of 5 August 2026.
What were Arm Holdings plc's latest quarterly results?
Arm Holdings plc reported revenue of $1.5 B and net profit of $0.3 B for the Mar 26 quarter. Revenue rose 20.2% and profit rose 47.6% year on year. Earnings per share were $0.29. The operating margin was 29.5%, 3.6 pp lower than a year earlier. — as of 5 August 2026.
What is Arm Holdings plc's revenue?
Arm Holdings plc reported revenue of $1.5 B in the Mar 26 quarter, +20.2% year on year. For the full FY26 fiscal year, revenue was $4.9 B (+22.7%). Over the last 4 years revenue compounded at 16.2% a year. — as of 5 August 2026.
What is Arm Holdings plc's profit?
Arm Holdings plc earned $0.3 B of net profit in the Mar 26 quarter, +47.6% year on year. Full-year FY26 profit was $0.9 B. The operating margin ran 29.5% in the latest quarter. — as of 5 August 2026.
What is Arm Holdings plc's market cap?
Arm Holdings plc's market capitalisation is $300 B at a stock price of $281. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Arm Holdings plc pay a dividend?
No — Arm Holdings plc has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Arm Holdings plc growing?
Yes — Arm Holdings plc is growing: latest-quarter revenue +20.2% year on year, profit +47.6%, and the margin −3.6 pp at 29.5%. The 4-year compound rates are 16.2% (revenue) and 7.3% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Arm Holdings plc performing?
Arm Holdings plc is in a confirmed uptrend, 20 weeks in. Its latest quarter's revenue rose 20.2% and profit rose 47.6% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 21 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Arm Holdings plc in?
Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +276.5% at its peak to +13.9% but is still expanding, ROCE holding at 10.1%. The read comes from the last 12 quarters of growth (revenue growth +23.0% latest, profit growth +13.9% latest, eps growth +12.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Arm Holdings plc in an uptrend?
Yes — the price is in a confirmed uptrend (week 20 of stage 2), trading +47.1% versus its 200-day average and at 52% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Arm Holdings plc beating the market?
On recent form, yes — Arm Holdings plc has been ahead of the S&P 500 on a trailing-13-week view for 21 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 2.9 years the stock moved +362% against the S&P 500's +74% — ahead of the index over the full window. — as of 5 August 2026.
Will Arm Holdings plc's stock price go up?
This page publishes no price forecast for Arm Holdings plc. What it measures instead: the stock price is $281, the price is in a confirmed uptrend 20 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Does Arm Holdings plc have too much debt?
No — Arm Holdings plc's debt-to-equity is 0.06. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.
What is Arm Holdings plc's capex?
Arm Holdings plc spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.6 B. — as of 5 August 2026.
What is Arm Holdings plc's cash flow?
Arm Holdings plc generated $1.5 B of operating cash flow in FY26 and $1.0 B of free cash flow after $0.6 B of capital spending. Reported profit that year was $0.9 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Arm Holdings plc's profit real cash?
Yes — over the last 3 fiscal years, 151% of Arm Holdings plc's reported profit arrived as operating cash. In FY26, operating cash was $1.5 B against reported profit of $0.9 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Arm Holdings plc?
On the balance sheet, the Z-score reads 43.93 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Arm Holdings plc in its business cycle?
Arm Holdings plc's FY26 operating margin was 18.3%, against a 5-year band of 3.4%–25.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 29.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Arm Holdings plc story?
The sharpest disagreement: the price moved +103.9% in a year while annual EPS moved +13.3% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Arm Holdings plc a stock worth studying right now?
This is not investment advice. The machine read: Arm Holdings plc's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.